Specialty Chemicals - Growth Set To Continue Despite Margin Blip: CareEdge

The operating profitability margins of this sector saw significant improvements in FY21 and FY22.

Chemical solution sit in a conical flask inside a lab. (Source: freepik)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

CareEdge Research Report

The Indian specialty chemicals sector has experienced significant growth, expanding by more than 17% in the last two fiscal years, ending FY22. According to us, this growth is expected to continue, with sales projected to increase by more than 19% until FY25. This growth is primarily driven by strong domestic demand and increased demand for exports, which has been bolstered by major global economies adopting the China plus one policy.

The operating profitability margins of this sector saw significant improvements in FY21 and FY22, largely due to supply chain disruptions caused by the spread of Covid-pandemic. However, these margins have moderated in nine months-FY23. We predict that there may be some pressure on operating profitability in the near future due to the recessionary conditions in major global economies. Despite this, the operating profitability margins are expected to remain healthy, hovering around 18%.

All sub-segments of the specialty chemicals sector have undertaken significant capex in the past three fiscal years, ended FY22, and a similar size of capex is currently underway and expected to be completed by the end of FY24. The next phase of growth is expected to occur post-completion and stabilisation of this capex.

Despite the large size of capex, the capital structure of the majority of sub-segments in the specialty chemicals sector remains comfortable. This is due to healthy internal accruals, which are expected to enable them to pursue substantial capex in the future.

Click on the attachment to read the full report:

CareEdge Report Speciality Chemicals.pdf
Read Document

Also Read: Chemical Sector Check - BASF’s Manufacturing Focus Shifting Eastwards: Prabhudas Lilladher

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google